Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs MEDICAMEN BI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES MEDICAMEN BI SUVEN LIFE SCIENCES/
MEDICAMEN BI
 
P/E (TTM) x -22.6 46.8 - View Chart
P/BV x 6.4 2.7 234.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 SUVEN LIFE SCIENCES   MEDICAMEN BI
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
MEDICAMEN BI
Mar-23
SUVEN LIFE SCIENCES/
MEDICAMEN BI
5-Yr Chart
Click to enlarge
High Rs941,219 7.7%   
Low Rs45559 8.1%   
Sales per share (Unadj.) Rs0.6111.4 0.6%  
Earnings per share (Unadj.) Rs-5.411.6 -46.6%  
Cash flow per share (Unadj.) Rs-5.116.7 -30.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs17.2152.8 11.3%  
Shares outstanding (eoy) m218.0712.65 1,723.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.88.0 1,399.9%   
Avg P/E ratio x-12.876.4 -16.8%  
P/CF ratio (eoy) x-13.553.3 -25.4%  
Price / Book Value ratio x4.05.8 69.3%  
Dividend payout %08.6 -0.0%   
Avg Mkt Cap Rs m15,13111,246 134.6%   
No. of employees `000NANA-   
Total wages/salary Rs m186201 92.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1351,409 9.6%  
Other income Rs m8425 343.2%   
Total revenues Rs m2201,433 15.3%   
Gross profit Rs m-1,196243 -491.5%  
Depreciation Rs m6564 102.8%   
Interest Rs m534 15.9%   
Profit before tax Rs m-1,183170 -693.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m023 0.0%   
Profit after tax Rs m-1,183147 -803.0%  
Gross profit margin %-883.617.3 -5,113.8%  
Effective tax rate %013.6 -0.0%   
Net profit margin %-873.510.5 -8,354.7%  
BALANCE SHEET DATA
Current assets Rs m3,4551,634 211.5%   
Current liabilities Rs m1,050826 127.2%   
Net working cap to sales %1,776.057.4 3,096.8%  
Current ratio x3.32.0 166.3%  
Inventory Days Days3,94835 11,235.5%  
Debtors Days Days2181,691 12.9%  
Net fixed assets Rs m1,3731,062 129.3%   
Share capital Rs m218127 172.4%   
"Free" reserves Rs m3,5351,806 195.7%   
Net worth Rs m3,7531,933 194.2%   
Long term debt Rs m09 0.0%   
Total assets Rs m4,8282,766 174.5%  
Interest coverage x-218.86.0 -3,632.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.5 5.5%   
Return on assets %-24.46.6 -372.3%  
Return on equity %-31.57.6 -413.5%  
Return on capital %-31.410.5 -298.0%  
Exports to sales %40.475.6 53.5%   
Imports to sales %839.86.3 13,277.8%   
Exports (fob) Rs m551,064 5.1%   
Imports (cif) Rs m1,13789 1,276.1%   
Fx inflow Rs m551,064 5.1%   
Fx outflow Rs m1,137136 836.4%   
Net fx Rs m-1,082928 -116.6%   
CASH FLOW
From Operations Rs m-1,031-63 1,639.1%  
From Investments Rs m-2,606-59 4,432.7%  
From Financial Activity Rs m3,955291 1,358.0%  
Net Cashflow Rs m317170 187.2%  

Share Holding

Indian Promoters % 69.6 43.2 161.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.5 1.1 137.3%  
FIIs % 0.5 0.1 383.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 56.8 53.6%  
Shareholders   68,959 10,639 648.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs MEDICAMEN BI

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs MEDICAMEN BI Share Price Performance

Period Suven Life Sciences MEDICAMEN BI S&P BSE HEALTHCARE
1-Day -1.27% -1.25% -1.23%
1-Month 6.38% 2.75% 1.07%
1-Year 91.69% -45.89% 50.86%
3-Year CAGR 11.98% -7.03% 14.38%
5-Year CAGR -15.22% -4.50% 19.01%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the MEDICAMEN BI share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of MEDICAMEN BI the stake stands at 43.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of MEDICAMEN BI.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

MEDICAMEN BI paid Rs 1.0, and its dividend payout ratio stood at 8.6%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of MEDICAMEN BI.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today(Pre-Open)

It was indeed a volatile trading session for Indian share markets yesterday.